A randomized, comparative study of Budesonide/formoterol versus Fluticasone/Salmeterol in COPD with asthma patients to improve oxidative stress and inflammatory mediators.
Phase of Trial: Phase II
Latest Information Update: 10 Mar 2011
At a glance
- Drugs Budesonide/formoterol (Primary) ; Salmeterol/fluticasone propionate (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Biomarker; Pharmacodynamics
- 10 Mar 2011 New trial record